All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 21:56, 10 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Aducanumab-avwa Drug Cont..png
- 21:56, 10 January 2023 Tejasvi Aryaputra talk contribs created page File:Aducanumab-avwa Drug Info .png
- 21:56, 10 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Aducanumab-avwa Drug Info .png
- 17:29, 5 January 2023 Tejasvi Aryaputra talk contribs created page Aducanumab-avwa (Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Aducanumab-avwa |aOrAn=an |drugClass=amyloid beta-directed antibody |indicationType=treatment |indication=treat Alzheimer’s disease |adverseReactions=ARIA-H microhemorrhage, fall, ARIA-Edema, ARIA-H superficial siderosis, and headache |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>...")
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Table 5 Clinical Studies.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Table 5 Clinical Studies.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Table 4 Pharmacokinetics.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Table 4 Pharmacokinetics.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Table 3 Adverse Reactions.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Table 3 Adverse Reactions.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Table 2 Dosage Modifications.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Table 2 Dosage Modifications.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Table 1 Dosages.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Table 1 Dosages.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Drug Label 2.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Drug Label 2.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Drug Label 1.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Drug Label 1.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs created page File:Rylaze Drug Insert.png
- 13:46, 3 January 2023 Tejasvi Aryaputra talk contribs uploaded File:Rylaze Drug Insert.png
- 19:12, 29 December 2022 Tejasvi Aryaputra talk contribs created page Asparaginase erwinia chrysanthemi (recombinant)-rywn (Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Asparaginase erwinia chrysanthemi (recombinant)-rywn |aOrAn=an |drugClass=asparagine specific enzyme |indicationType=treatment |indication=acute lymphoblastic leukemia and lymphoblastic lymphoma in patients who are allergic to E. coli-derived asparaginase products, as a component of a chemotherapy regimen |adverseReactions=musculoskeletal pain, febrile neutropenia, hypokalemia, abnorm...")
- 13:54, 29 December 2022 Jair Basantes de la Calle talk contribs created page File:Upper GI bleeding. Adapted from ACG Clinical Guideline- Upper Gastrointestinal and Ulcer Bleeding.png
- 13:54, 29 December 2022 Jair Basantes de la Calle talk contribs uploaded File:Upper GI bleeding. Adapted from ACG Clinical Guideline- Upper Gastrointestinal and Ulcer Bleeding.png
- 21:21, 8 December 2022 Jair Basantes de la Calle talk contribs created page File:Stage A and Stage B recommendations for HF. Adapted from 2022 AHA-ACC-HFSA Guideline for the Management of Heart Failure.png
- 21:21, 8 December 2022 Jair Basantes de la Calle talk contribs uploaded File:Stage A and Stage B recommendations for HF. Adapted from 2022 AHA-ACC-HFSA Guideline for the Management of Heart Failure.png
- 19:24, 8 December 2022 Jair Basantes de la Calle talk contribs created page File:Recommendation for blood pressure management. Adapted from the 2019 ACC-AHA Guideline on the Primary Prevention of Cardiovascular Disease. .png
- 19:24, 8 December 2022 Jair Basantes de la Calle talk contribs uploaded File:Recommendation for blood pressure management. Adapted from the 2019 ACC-AHA Guideline on the Primary Prevention of Cardiovascular Disease. .png
- 18:37, 8 December 2022 Alberto Castro Molina talk contribs created page Partial anomalous pulmonary venous connection surgery (Created page with "== 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines<ref name="pmid30121240">{{cite journal| author=Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM | display-authors=etal| title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the America...") Tag: Visual edit
- 18:28, 8 December 2022 Jair Basantes de la Calle talk contribs created page File:Primary Prevention of ASCVD per age group.png
- 18:28, 8 December 2022 Jair Basantes de la Calle talk contribs uploaded File:Primary Prevention of ASCVD per age group.png
- 18:25, 8 December 2022 Alberto Castro Molina talk contribs created page Partial anomalous pulmonary venous connection other imaging findings (Created page with "== 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines<ref name="pmid30121240">{{cite journal| author=Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM | display-authors=etal| title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the America...") Tag: Visual edit
- 17:12, 8 December 2022 Jair Basantes de la Calle talk contribs created page File:HbA1c 6,5% .png
- 17:12, 8 December 2022 Jair Basantes de la Calle talk contribs uploaded File:HbA1c 6,5% .png
- 12:52, 6 December 2022 Jair Basantes de la Calle talk contribs created page Pharmacotherapy in patients undergoing CABG (Pharmacotherapy in patients undergoing CABG Jump to navigationJump to search) Tag: Visual edit: Switched
- 21:22, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction future or investigational therapies to Unstable angina non ST elevation myocardial infarction future or investigational therapies
- 21:22, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction cost-effectiveness of therapy to Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy
- 21:22, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines quality care and outcomes
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for influenza to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for influenza
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for patient education to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for patient education
- 21:21, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for physical activity to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for physical activity
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy
- 21:20, 5 December 2022 Jair Basantes de la Calle talk contribs moved page Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers to Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers